Stay updated on Oncolytics Biotech Press Releases

Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Oncolytics Biotech Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a press release about the domicile change to the United States (April 1, 2026). Deleted a press release expanding the Gastrointestinal Tumor Scientific Advisory Board with the addition of Dr. Eileen O’Reilly, Dr. Neil Segal, and Dr. Van Morris (January 7, 2026).
    Difference
    1%
    Check dated 2026-04-02T00:44:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a March 19, 2026 press release about presenting new data at AACR 2026 and removed the December 16, 2025 press release on KRAS-Mutant metastatic colorectal cancer.
    Difference
    1%
    Check dated 2026-03-25T21:11:10.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page adds a new press release about a randomized colorectal cancer study and adds navigation to Our Mission, Board of Directors, and Resources. It removes the Media, Careers, Contact, and News sections.
    Difference
    6%
    Check dated 2026-03-04T12:56:15.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added: 'Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer' (Feb 24, 2026). Removed: 'Oncolytics Biotech® Provides Update on Special Meeting of Shareholders' (Nov 20, 2025).
    Difference
    1%
    Check dated 2026-02-25T09:19:55.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Added a press release announcing FDA Fast Track designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer (Feb 4, 2026). Removed a press release about aligning FDA pivotal study design for Pelareorep in First-Line Pancreatic Cancer (Nov 19, 2025).
    Difference
    1%
    Check dated 2026-02-11T09:19:20.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added two January 2026 press releases to the News page (Jan 15 and Jan 14). Removed two older items (Nov 4 and Oct 28, 2025).
    Difference
    6%
    Check dated 2026-01-21T04:30:43.000Z thumbnail image

Stay in the know with updates to Oncolytics Biotech Press Releases

Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.